Carim V. Khouzami - Jan 29, 2024 Form 4 Insider Report for EXELON CORP (EXC)

Role
CEO of BGE
Signature
Elizabeth M Hensen, attorney-in-fact for Carim V Khouzami
Stock symbol
EXC
Transactions as of
Jan 29, 2024
Transactions value $
-$595,660
Form type
4
Date filed
1/31/2024, 04:10 PM
Previous filing
Mar 20, 2023
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock +Options Exercise +2,251 +50.04% 6,749 Jan 29, 2024 Direct F1
transaction EXC Common Stock +Options Exercise +2,253 +33.38% 9,002 Jan 29, 2024 Direct F1
transaction EXC Common Stock +Options Exercise +3,046 +33.84% 12,048 Jan 29, 2024 Direct F1
transaction EXC Common Stock +Options Exercise +21,236 +176.26% 33,284 Jan 29, 2024 Direct F2
transaction EXC Common Stock -Tax liability -$346,936 -9,831 -29.54% $35.29 23,453 Jan 29, 2024 Direct
transaction EXC Common Stock -Disposed to Issuer -$248,724 -7,048 -30.05% $35.29 16,405 Jan 29, 2024 Direct
holding EXC Common Stock 401k 8,757 Jan 29, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2024 Restricted Stock Units +Grant/Award +7,721 7,721 Jan 29, 2024 Common Stock 7,721 Direct F1
transaction EXC 2023 Restricted Stock Units -Options Exercise -2,251 -33.33% 4,503 Jan 29, 2024 Common Stock 2,251 Direct F1, F4
transaction EXC 2022 Restricted Stock Units -Options Exercise -2,253 -50.01% 2,252 Jan 29, 2024 Common Stock 2,253 Direct F1, F5
transaction EXC 2021 Restricted Stock Units -Options Exercise -3,046 -100% 0 Jan 29, 2024 Common Stock 3,046 Direct F1, F6
transaction EXC 2021-2023 Performance Shares +Grant/Award +21,236 21,236 Jan 29, 2024 Common Stock 21,236 Direct F2
transaction EXC 2021-2023 Performance Shares -Options Exercise -21,236 -100% 0 Jan 29, 2024 Common Stock 21,236 Direct F2
holding EXC Deferred phantom share equivalents 760 Jan 29, 2024 Common Stock 760 Direct F7, F8

Explanation of Responses:

Id Content
F1 Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Comp. Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.
F2 Performance share award granted under the Exelon LTIP for the three-year performance period referenced in Column 1 based upon the Comp. Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
F3 Balance as of December 31, 2023.
F4 Pre-vesting balance includes 238 shares acquired through automatic dividend reinvestment during 2023.
F5 Pre-vesting balance includes 159 shares acquired through automatic dividend reinvestment during 2023.
F6 Pre-vesting balance includes 107 shares acquired through automatic dividend reinvestment during 2023.
F7 Balance includes 26 additional phantom share equivalents that were accrued through automatic dividend reinvestment during 2023.
F8 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.